3 results
Approved WMOCompleted
To explore the safety, tolerability and the pharmacokinetic profile of 2-IB when given on top of therapeutic hypothermia.
Approved WMOCompleted
The primary objective of this study is to evaluate the short term safety and tolerability, and pharmacokinetic properties of 2-IB when administered to adult patients after OHCA. Secondary objectives include safety and efficacy parameters at 30 days…
Approved WMORecruiting
Primary Objective: to assess the feasibility of the use of BabyCheck combined with standard PO for infants < six months of age presented at the emergency GP post. Secondary Objective(s): 1. To assess the sensitivity and specificity of the…